News | December 09, 2007

Integra LifeSciences Launches Radionics CRW BiopsyPlus Kit

December 10, 2007 - Integra LifeSciences Holdings Corp. announced the launch of the Radionics CRW BiopsyPlus Kit, which is designed to simplify the use of the Nashold Biopsy Needle when used with the Radionics CRW stereotactic system, combining all the accessories for the procedure in a single sterile package and requires no assembly or adjustments.

The disposable side cutting brain biopsy needle was originally developed by the renowned neurosurgeon Blaine S. Nashold, Jr., M.D., Professor Emeritus of Surgery, Division of Neurosurgery, Duke University Medical Center and Eric Cosman, Ph.D., past-president and former owner of Radionics, in the 1980's to work in conjunction with Radionics stereotactic surgery devices.

The combination of the Radionics CRW stereotactic system and the Nashold Biopsy needle has long provided neurosurgeons with the confidence to perform precise and safe brain biopsies.

"Integra's new Radionics CRWbiopsy system simplifies brain biopsies without compromising accuracy or confidence," stated Dr. Allan Friedman, Chief of Neurosurgery at Duke University Medical Center in Durham, North Carolina. "Advances like this enable neurosurgeons to concentrate more attention on the patient."

Approximately 17,000 brain biopsies for cancer patients are performed in the U.S. annually and are vital to determining the appropriate management of a patient's cancer. Stereotactic systems are used when maximum accuracy and minimal collateral involvement are essential.

For more information: